[The inhibition of thrombocyte aggregation in vitro and in vivo].
D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001095:Arachidonic Acids / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D004176:Dipyridamole / Q000494:pharmacology; D005228:Fatty Acids, Essential / Q000494:pharmacology; D005340:Fibrinogen / Q000494:pharmacology; D005459:Fluorides / Q000494:pharmacology; D005841:Gentisates / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007461:Iodoacetates / Q000494:pharmacology; D009539:Nicotinic Acids / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects; D011453:Prostaglandins / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D013927:Thrombosis / Q000517:prevention & control*; D014665:Vasodilator Agents / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D001095:Arachidonic Acids; D005228:Fatty Acids, Essential; D005841:Gentisates; D007461:Iodoacetates; D009539:Nicotinic Acids; D011453:Prostaglandins; D014665:Vasodilator Agents; D004176:Dipyridamole; D005340:Fibrinogen; D012964:Sodium; D010208:Papaverine; D010653:Phenylbutazone; D005459:Fluorides; D001241:Aspirin
Die Hemmung der Thrombozytenaggregation in vitro and in vivo.